SGLT2 Inhibitors Clinical Trials

10 clinical trials for SGLT2 Inhibitors across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF Patients — RECRUITING
• Efficacy of SGLT2 Inhibitors in Adults With Sepsis — RECRUITING · NA
• Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) — RECRUITING · PHASE2
• SGLT-2 Inhibitors and Lower Urinary Tract Symptoms — ACTIVE_NOT_RECRUITING
• Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients — ACTIVE_NOT_RECRUITING · PHASE4
• CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF — NOT_YET_RECRUITING · PHASE4
• Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients — COMPLETED · PHASE4
• SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients — COMPLETED · PHASE4
• Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels — OTHER
• SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study — OTHER

Refine this search